U1DA — MOLOGEN Lifescience AG Cashflow Statement
0.000.00%
FinancialsHighly SpeculativeMicro Cap
Annual cashflow statement for MOLOGEN Lifescience AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2015 December 31st | |
|---|---|
| Period Length: | 10 M |
| Source: | ARS |
| Standards: | GAS |
| Status: | Final |
| Net Income/Starting Line | 0.025 |
| Depreciation | |
| Non-Cash Items | -0.232 |
| Other Non-Cash Items | |
| Changes in Working Capital | -0.063 |
| Change in Other Assets | |
| Change in Other Liabilities | |
| Other Operating Cash Flow | |
| Cash from Operating Activities | -0.177 |
| Capital Expenditures | -0.404 |
| Purchase of Fixed Assets | |
| Purchase / Acquisition of Intangibles | |
| Other Investing Cash Flow Items | 0.013 |
| Sale of Fixed Assets | |
| Cash from Investing Activities | -0.392 |
| Net Issuance / Retirement of Stock | |
| Net Issuance / Retirement of Debt | |
| Cash from Financing Activities | 0.579 |
| Beginning Cash Balance | |
| Ending Cash Balance | |
| Net Change in Cash | 0.01 |